HRT Financial’s Ibere Pharmaceuticals Units, each consisting of one Class A ordinary share and one-half of one Redeemable Warrant IBER.U Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
2022
Q4
$649K Hold
2022
Q3
$644K Hold
2022
Q2
$638K Hold
2022
Q1
$641K Hold
2021
Q4
$651K Hold
2021
Q3
$649K Hold
2021
Q2
$653K Hold
2021
Q1
$640K Buy